Strohl WR - Search Results

1

Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Strohl WR, Naso M. Strohl WR, et al. Antibodies (Basel). 2019 Jul 3;8(3):41. doi: 10.3390/antib8030041. Antibodies (Basel). 2019. PMID: 31544847 Free PMC article. Review.

2

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.

Naso MF, Tomkowicz B, Perry WL 3rd, Strohl WR. Naso MF, et al. Among authors: strohl wr. BioDrugs. 2017 Aug;31(4):317-334. doi: 10.1007/s40259-017-0234-5. BioDrugs. 2017. PMID: 28669112 Free PMC article. Review.

3

Secretion of Fc-amidated peptide fusion proteins by Chinese hamster ovary cells.

Carlson KR, Pomerantz SC, Li J, Vafa O, Naso M, Strohl W, Mains RE, Eipper BA. Carlson KR, et al. BMC Biotechnol. 2015 Jun 27;15:61. doi: 10.1186/s12896-015-0173-5. BMC Biotechnol. 2015. PMID: 26116580 Free PMC article.

4

Optimizing production of Fc-amidated peptides by Chinese hamster ovary cells.

Carlson K, Pomerantz SC, Vafa O, Naso M, Strohl W, Mains RE, Eipper BA. Carlson K, et al. BMC Biotechnol. 2015 Oct 16;15:95. doi: 10.1186/s12896-015-0210-4. BMC Biotechnol. 2015. PMID: 26475607 Free PMC article.

5

Current progress in innovative engineered antibodies.

Strohl WR. Strohl WR. Protein Cell. 2018 Jan;9(1):86-120. doi: 10.1007/s13238-017-0457-8. Epub 2017 Aug 18. Protein Cell. 2018. PMID: 28822103 Free PMC article. Review.

6

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Strohl WR, Ku Z, An Z, Carroll SF, Keyt BA, Strohl LM. Strohl WR, et al. BioDrugs. 2022 May;36(3):231-323. doi: 10.1007/s40259-022-00529-7. Epub 2022 Apr 27. BioDrugs. 2022. PMID: 35476216 Free PMC article. Review.

7

An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.

Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, Scallon B, Teplyakov A, Malia TJ, Strohl WR. Vafa O, et al. Among authors: strohl wr. Methods. 2014 Jan 1;65(1):114-26. doi: 10.1016/j.ymeth.2013.06.035. Epub 2013 Jul 17. Methods. 2014. PMID: 23872058

8

Optimization of Fc-mediated effector functions of monoclonal antibodies.

Strohl WR. Strohl WR. Curr Opin Biotechnol. 2009 Dec;20(6):685-91. doi: 10.1016/j.copbio.2009.10.011. Epub 2009 Nov 4. Curr Opin Biotechnol. 2009. PMID: 19896358 Review.

9

Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters.

Strohl WR. Strohl WR. BioDrugs. 2015 Aug;29(4):215-39. doi: 10.1007/s40259-015-0133-6. BioDrugs. 2015. PMID: 26177629 Free PMC article. Review.

10

IgG2m4, an engineered antibody isotype with reduced Fc function.

An Z, Forrest G, Moore R, Cukan M, Haytko P, Huang L, Vitelli S, Zhao JZ, Lu P, Hua J, Gibson CR, Harvey BR, Montgomery D, Zaller D, Wang F, Strohl W. An Z, et al. MAbs. 2009 Nov-Dec;1(6):572-9. doi: 10.4161/mabs.1.6.10185. MAbs. 2009. PMID: 20073128 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters